title: Response to "what constitutes scientific justification for inclusion of recovery assessment in pre-clinical studies supporting first time in man (FTIM)?" Sally Robinson and Ruth Roberts, Drug Safety and Metabolism, AstraZeneca, Alderley Park, Macclesfield, UK.
authors.affiliation: MHRA, United Kingdom.
authors.forename: David R
authors.initials: DR
authors.lastname: Jones
mesh_terms: D015507:Drugs, Investigational / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans
chemical_list: D015507:Drugs, Investigational